New drug DD-S052P takes first step in human testing
NCT ID NCT07347223
First seen Jan 17, 2026 · Last updated May 08, 2026 · Updated 16 times
Summary
This early-stage study tested the safety of a new drug called DD-S052P in 64 healthy adults. Participants received either the drug or a placebo through an IV, with some getting a single dose and others multiple doses over several days. The goal was to check for side effects and how the drug moves through the body, helping researchers decide if it's safe enough for future studies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
HLB Science
Seoul, Seoul, 05836, South Korea
Conditions
Explore the condition pages connected to this study.